M. Tariq Bhatti

M. Tariq Bhatti

Auto-generated profile, based on publicly available information

M. Tariq Bhatti

Department of Ophthalmology, The Permanente Medical Group, Kaiser Permanente, Northern California, Roseville, California

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 January 2020 in Survey of Ophthalmology
Verified
Journal Article
Closed access
KLKaty C. Liu
Katy C. Liu
DFDavid Fleischman
David Fleischman
ALAndrew G. Lee
Andrew G. Lee
HKHanspeter E. Killer
Hanspeter E. Killer
JCJohn J. Chen
John J. Chen
MBM. Tariq Bhatti
M. Tariq Bhatti

1 March 2020 in American Journal of Ophthalmology Case Reports
Verified
Journal Article
Open access
MGMaria D. Garcia
Maria D. Garcia
MHMinjun Hur
Minjun Hur
JCJohn J. Chen
John J. Chen
MBM. Tariq Bhatti
M. Tariq Bhatti
We detail a case of cobalt toxicity with visual and systemic complications, review the pathogenic process for the optic neuropathy and retinopathy, and discuss the controversy of metallic hip prosthesis. A 59-year-old female with a history of multiple left hip arthroplasties presented to our clinic with bilateral visual loss. The year prior, she had failure of the hip implant necessitating revision surgery with placement of a chrome-cobalt head. A few months after surgery, she began experiencing blurred and "white, spotty" vision in both eyes in addition to hypothyroidism, cardiomyopathy and neuropathy. The possibility of the patient's symptoms being due to cobalt toxicity from her hip prosthesis was proposed and she was found to have a serum cobalt level >1000 μg/L (normal 0-0.9 ng/mL). Visual acuity was 20/600 in the right and 20/800 in the left eye. There was bilateral temporal optic disc pallor. Goldmann visual field testing demonstrated bilateral central scotomas, optical coherence tomography (OCT) showed severe ganglion cell layer-inner plexiform layer (GCLIPL) thinning and multifocal electroretinography (mfERG) demonstrated decreased amplitudes in both eyes. She underwent a total hip revision arthroplasty with extensive debridement of "black sludge" found within a pseudocapsule. Four days after surgery, cobalt serum levels had significantly decreased to 378 ng/mL. One month after surgery, she had significant improvement in visual acuity (20/150 right eye, 20/250 left eye), Goldmann visual field testing, and mfERG. OCT showed retinal nerve fiber thinning and persistent GCLIPL thinning in both eyes. Excessive cobalt levels can result in systemic toxicity leading to visual changes, peripheral neuropathy, hearing loss, cognitive deficits, cardiomyopathy and hypothyroidism. In recent years it has become apparent that cobalt toxicity can be associated with metal-on-metal total hip arthroplasty, or the grinding effects of retained ceramic particles from a fractured ceramic head on a cobalt-chromium femoral head prosthesis.

25 November 2021 in American Journal of Neuroradiology
Verified
Journal Article
Closed access
PDF file
OJO. Jones
O. Jones
JCJ. Cutsforth-Gregory
J. Cutsforth-Gregory
JCJohn Chen
John Chen
MBM.T. Bhatti
M.T. Bhatti
JHJ. Huston
J. Huston
WBWaleed Brinjikji
Waleed Brinjikji
BACKGROUND AND PURPOSE: Research suggests a connection between idiopathic intracranial hypertension and the cerebral glymphatic system. We hypothesized that visible dilated perivascular spaces, possible glymphatic pathways, would be more prevalent in patients with idiopathic intracranial hypertension. This prevalence could provide a biomarker and add evidence to the glymphatic connection in the pathogenesis of idiopathic intracranial hypertension. MATERIALS AND METHODS: We evaluated 36 adult (older than 21 years of age) patients with idiopathic intracranial hypertension and 19 controls, 21–69 years of age, who underwent a standardized MR imaging protocol that included high-resolution precontrast T2- and T1-weighted images. All patients had complete neuro-ophthalmic examinations for papilledema. The number of visible perivascular spaces was evaluated using a comprehensive 4-point qualitative rating scale, which graded the number of visible perivascular spaces in the centrum semiovale and basal ganglia; a 2-point scale was used for the midbrain. Readers were blinded to patient diagnoses. Continuous variables were compared using a Student t test. RESULTS: The mean number of visible perivascular spaces overall was greater in the idiopathic intracranial hypertension group than in controls (4.5 [SD, 1.9] versus 2.9 [SD, 1.9], respectively; P = .004). This finding was significant for centrum semiovale idiopathic intracranial hypertension (2.3 [SD, 1.4] versus controls, 1.3 [SD, 1.1], P = .003) and basal ganglia idiopathic intracranial hypertension (1.7 [SD, 0.6] versus controls, 1.2 [SD, 0.7], P = .009). There was no significant difference in midbrain idiopathic intracranial hypertension (0.5 [SD, 0.5] versus controls, 0.4 [SD, 0.5], P = .47). CONCLUSIONS: Idiopathic intracranial hypertension is associated with an increased number of visible intracranial perivascular spaces. This finding provides insight into the pathophysiology of idiopathic intracranial hypertension, suggesting a possible relationship between idiopathic intracranial hypertension and glymphatic dysfunction and providing another useful biomarker for the disease.

5 July 2019 in Current Treatment Options in Neurology
Verified
Journal Article
Closed access
PDF file
AFAaron M. Fairbanks
Aaron M. Fairbanks
MSMatthew R. Starr
Matthew R. Starr
JCJohn J. Chen
John J. Chen
MBM. Tariq Bhatti
M. Tariq Bhatti

1 April 2021 in Ophthalmology
Verified
Journal Article
Closed access
SMSasha A. Mansukhani
Sasha A. Mansukhani
DMDev G. Mehta
Dev G. Mehta
DRDeborah L. Renaud
Deborah L. Renaud
MWMark A. Whealy
Mark A. Whealy
JCJohn Chen
John Chen
MBM. Tariq Bhatti
M. Tariq Bhatti